View in EDS PDF Full Text

End-point definition and trial design to advance tuberculosis vaccine development.

Saved in:
Bibliographic Details
Title: End-point definition and trial design to advance tuberculosis vaccine development.
Authors: Garcia-Basteiro AL; Centro de Investigação em Sade de Manhiça (CISM), Maputo, Mozambique alberto.garcia-basteiro@manhica.net.; ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFECT), Barcelona, Spain., White RG; London School of Hygiene and Tropical Medicine, London, UK., Tait D; International AIDS Vaccine Initiative (IAVI) NPC, Cape Town, South Africa., Schmidt AC; Bill and Melinda Gates Medical Research Institute, Cambridge, MA, USA., Rangaka MX; Institute for Global Health and MRC Clinical Trials Unit at University College London, London, UK.; CIDRI-AFRICA, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Quaife M; London School of Hygiene and Tropical Medicine, London, UK., Nemes E; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Dept of Pathology, University of Cape Town, Cape Town, South Africa., Mogg R; Takeda Pharmaceutical Company Limited, Cambridge, MA, USA., Hill PC; Centre for International Health, University of Otago, Dunedin, New Zealand., Harris RC; London School of Hygiene and Tropical Medicine, London, UK.; Sanofi Pasteur, Singapore., Hanekom WA; Africa Health Research Institute, KwaZulu-Natal, South Africa.; Division of Infection and Immunity, University College London, London, UK., Frick M; Treatment Action Group, New York, NY, USA., Fiore-Gartland A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Evans T; Vaccitech, Oxford, UK., Dagnew AF; Bill and Melinda Gates Medical Research Institute, Cambridge, MA, USA., Churchyard G; The Aurum Institute, Parktown, South Africa.; Vanderbilt University, Nashville, TN, USA.; University of the Witwatersrand, Johannesburg, South Africa., Cobelens F; Dept of Global Health and Amsterdam Institute for Global health and development, Amsterdam University Medical Centres, Amsterdam, The Netherlands., Behr MA; Dept of Medicine, McGill University; McGill International TB Centre, Montreal, QC, Canada., Hatherill M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Dept of Pathology, University of Cape Town, Cape Town, South Africa.
Source: European respiratory review : an official journal of the European Respiratory Society [Eur Respir Rev] 2022 Jun 07; Vol. 31 (164). Date of Electronic Publication: 2022 Jun 07 (Print Publication: 2022).
Publication Type: Journal Article; Review
Journal Info: Publisher: European Respiratory Society Country of Publication: England NLM ID: 9111391 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1600-0617 (Electronic) Linking ISSN: 09059180 NLM ISO Abbreviation: Eur Respir Rev Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35675923
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: End-point definition and trial design to advance tuberculosis vaccine development.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Garcia-Basteiro+AL%22">Garcia-Basteiro AL</searchLink>; Centro de Investigação em Sade de Manhiça (CISM), Maputo, Mozambique alberto.garcia-basteiro@manhica.net.; ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFECT), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22White+RG%22">White RG</searchLink>; London School of Hygiene and Tropical Medicine, London, UK.<br /><searchLink fieldCode="AU" term="%22Tait+D%22">Tait D</searchLink>; International AIDS Vaccine Initiative (IAVI) NPC, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Schmidt+AC%22">Schmidt AC</searchLink>; Bill and Melinda Gates Medical Research Institute, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Rangaka+MX%22">Rangaka MX</searchLink>; Institute for Global Health and MRC Clinical Trials Unit at University College London, London, UK.; CIDRI-AFRICA, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Quaife+M%22">Quaife M</searchLink>; London School of Hygiene and Tropical Medicine, London, UK.<br /><searchLink fieldCode="AU" term="%22Nemes+E%22">Nemes E</searchLink>; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Dept of Pathology, University of Cape Town, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Mogg+R%22">Mogg R</searchLink>; Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Hill+PC%22">Hill PC</searchLink>; Centre for International Health, University of Otago, Dunedin, New Zealand.<br /><searchLink fieldCode="AU" term="%22Harris+RC%22">Harris RC</searchLink>; London School of Hygiene and Tropical Medicine, London, UK.; Sanofi Pasteur, Singapore.<br /><searchLink fieldCode="AU" term="%22Hanekom+WA%22">Hanekom WA</searchLink>; Africa Health Research Institute, KwaZulu-Natal, South Africa.; Division of Infection and Immunity, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Frick+M%22">Frick M</searchLink>; Treatment Action Group, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Fiore-Gartland+A%22">Fiore-Gartland A</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Evans+T%22">Evans T</searchLink>; Vaccitech, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Dagnew+AF%22">Dagnew AF</searchLink>; Bill and Melinda Gates Medical Research Institute, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Churchyard+G%22">Churchyard G</searchLink>; The Aurum Institute, Parktown, South Africa.; Vanderbilt University, Nashville, TN, USA.; University of the Witwatersrand, Johannesburg, South Africa.<br /><searchLink fieldCode="AU" term="%22Cobelens+F%22">Cobelens F</searchLink>; Dept of Global Health and Amsterdam Institute for Global health and development, Amsterdam University Medical Centres, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Behr+MA%22">Behr MA</searchLink>; Dept of Medicine, McGill University; McGill International TB Centre, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Hatherill+M%22">Hatherill M</searchLink>; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Dept of Pathology, University of Cape Town, Cape Town, South Africa.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229111391%22">European respiratory review : an official journal of the European Respiratory Society</searchLink> [Eur Respir Rev] 2022 Jun 07; Vol. 31 (164). <i>Date of Electronic Publication: </i>2022 Jun 07 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22European+Respiratory+Society%22">European Respiratory Society </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9111391 <i>Publication Model: </i>Electronic-Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1600-0617 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209059180%22">09059180 </searchLink><i>NLM ISO Abbreviation: </i>Eur Respir Rev <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35675923
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1183/16000617.0044-2022
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: End-point definition and trial design to advance tuberculosis vaccine development.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Garcia-Basteiro AL
      – PersonEntity:
          Name:
            NameFull: White RG
      – PersonEntity:
          Name:
            NameFull: Tait D
      – PersonEntity:
          Name:
            NameFull: Schmidt AC
      – PersonEntity:
          Name:
            NameFull: Rangaka MX
      – PersonEntity:
          Name:
            NameFull: Quaife M
      – PersonEntity:
          Name:
            NameFull: Nemes E
      – PersonEntity:
          Name:
            NameFull: Mogg R
      – PersonEntity:
          Name:
            NameFull: Hill PC
      – PersonEntity:
          Name:
            NameFull: Harris RC
      – PersonEntity:
          Name:
            NameFull: Hanekom WA
      – PersonEntity:
          Name:
            NameFull: Frick M
      – PersonEntity:
          Name:
            NameFull: Fiore-Gartland A
      – PersonEntity:
          Name:
            NameFull: Evans T
      – PersonEntity:
          Name:
            NameFull: Dagnew AF
      – PersonEntity:
          Name:
            NameFull: Churchyard G
      – PersonEntity:
          Name:
            NameFull: Cobelens F
      – PersonEntity:
          Name:
            NameFull: Behr MA
      – PersonEntity:
          Name:
            NameFull: Hatherill M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 07
              M: 06
              Text: 2022 Jun 07
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1600-0617
          Numbering:
            – Type: volume
              Value: 31
            – Type: issue
              Value: 164
          Titles:
            – TitleFull: European respiratory review : an official journal of the European Respiratory Society
              Type: main
ResultId 1